These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
562 related articles for article (PubMed ID: 2153277)
1. Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast. Visscher DW; Zarbo RJ; Greenawald KA; Crissman JD Pathol Annu; 1990; 25 Pt 1():171-210. PubMed ID: 2153277 [TBL] [Abstract][Full Text] [Related]
2. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer]. Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560 [TBL] [Abstract][Full Text] [Related]
3. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer. Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432 [TBL] [Abstract][Full Text] [Related]
4. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients. Gazic B; Pizem J; Bracko M; Cufer T; Borstnar S; Pohar-Marinsek Z; Us-Krasovec M Cytopathology; 2008 Oct; 19(5):294-302. PubMed ID: 18070112 [TBL] [Abstract][Full Text] [Related]
6. Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer. Baak JP; Chin D; van Diest PJ; Ortiz R; Matze-Cok P; Bacus SS Lab Invest; 1991 Feb; 64(2):215-23. PubMed ID: 1671789 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry. Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053 [TBL] [Abstract][Full Text] [Related]
8. Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness. Gasparini G; Pozza F; Meli S; Reitano M; Santini G; Bevilacqua P Anticancer Res; 1991; 11(6):2015-21. PubMed ID: 1776834 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of DNA image cytometry in Libyan breast cancer. Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y Oncology; 2012; 83(3):165-76. PubMed ID: 22906963 [TBL] [Abstract][Full Text] [Related]
10. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters. Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041 [TBL] [Abstract][Full Text] [Related]
11. DNA analysis and S-phase fraction determination by flow cytometric analysis of infiltrating lobular carcinoma of the breast. Frost AR; Karcher DS; Terahata S; Siegel RS; Silverberg SG Mod Pathol; 1996 Sep; 9(9):930-7. PubMed ID: 8878026 [TBL] [Abstract][Full Text] [Related]
12. Predictive value of flow cytometry for metastatic potential in breast cancer. Schmidt H; Wei JP; Yeh KA Am Surg; 1999 May; 65(5):434-8. PubMed ID: 10231212 [TBL] [Abstract][Full Text] [Related]
13. Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor. Chang J; Clark GM; Allred DC; Mohsin S; Chamness G; Elledge RM Cancer; 2003 Feb; 97(3):545-53. PubMed ID: 12548595 [TBL] [Abstract][Full Text] [Related]
14. DNA analysis in advanced breast cancer. Leivonen M; Krogerus L; Nordling S Cancer Detect Prev; 1994; 18(2):87-96. PubMed ID: 8025900 [TBL] [Abstract][Full Text] [Related]
15. Reproducibility in DNA flow cytometric analysis of breast cancer: comparison of 12 laboratories' results for 67 sample homogenates. Baldetorp B; Bendahl PO; Fernö M; Alanen K; Delle U; Falkmer U; Hansson-Aggesjö B; Höckenström T; Lindgren A; Mossberg L Cytometry; 1995 Jun; 22(2):115-27. PubMed ID: 7587742 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of DNA ploidy and S-phase fraction in stage I endometrial carcinoma. Pfisterer J; Kommoss F; Sauerbrei W; Rendl I; Kiechle M; Kleine W; Pfleiderer A Gynecol Oncol; 1995 Aug; 58(2):149-56. PubMed ID: 7622098 [TBL] [Abstract][Full Text] [Related]
17. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study. Ottesen GL APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968 [TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in breast cancer. Merkel DE; Osborne CK Hematol Oncol Clin North Am; 1989 Dec; 3(4):641-52. PubMed ID: 2558104 [TBL] [Abstract][Full Text] [Related]
19. DNA flow cytometric analysis of clinical stage I endometrial carcinomas with lymph node metastases. Coleman RL; Schink JC; Miller DS; Bauer KD; August CZ; Rademaker AW; Lurain JR Gynecol Oncol; 1993 Jul; 50(1):20-4. PubMed ID: 8349159 [TBL] [Abstract][Full Text] [Related]
20. S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study. Chassevent A; Jourdan ML; Romain S; Descotes F; Colonna M; Martin PM; Bolla M; Spyratos F Clin Cancer Res; 2001 Apr; 7(4):909-17. PubMed ID: 11309341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]